Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

被引：0

作者：

Marx, Nikolaus ^{[1
]}

Mueller-Wieland, Dirk ^{[1
]}

Espinola-Klein, Christine ^{[2
]}

Halle, Martin ^{[3
]}

Birkenhagen, Annette ^{[4
]}

Diemert, Patrick ^{[5
]}

Mahfoud, Felix ^{[6
,9
]}

Wienbergen, Harm ^{[7
,8
]}

Schuett, Katharina ^{[1
]}

机构：

[1] Uniklin RTWH Aachen, Med Klin Kardiol Angiol & Internist Intensivmed 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] Univ Med Mainz, Zent Kardiol, Kardiol Angiol 3, Mainz, Germany

[3] Tech Univ Munich, TUM Sch Med & Hlth, Pravent Sportmed & Sportkardiol, TUM Univ klinikum rechts Isar, Munich, Germany

[4] Kardiol Angiol Praxis, Stollberg, Germany

[5] Univ Herz & Gefasszentrum Hamburg, Klinik & Poliklin Kardiol, Hamburg, Germany

[6] Univ klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

[7] Bremer Inst Herz & Kreislaufforsch, Stiftung Bremer Herzen, Gesundheit Nord Klinikverbund Bremen, Bremen, Germany

[8] Univ Lubeck, Med Klin 2, Lubeck, Germany

[9] Deutsch Gesell Kardiol Herz & Kreislaufforsch eV D, Kommiss Klin Kardiovask Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 03期

关键词：

Diabetes mellitus; Cardiovascular disease; Heart failure; Kidney failure; EJECTION FRACTION; KIDNEY OUTCOMES; HEART-FAILURE; TYPE-2; EMPAGLIFLOZIN; METAANALYSIS; FINERENONE; MORTALITY;

D O I：

10.1007/s12181-024-00689-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

引用

页码：256 / 265

页数：10

共 50 条

[31] Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
Schernthaner, Guntram
Jarvis, Sarah
Lotan, Chaim
Prazny, Martin
Wanner, Christoph
Wascher, Thomas C.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 69 - 79
[32] Kommentar zu den Leitlinien (2018) der ESC zum Management von kardiovaskulären Erkrankungen in der SchwangerschaftComments on the guidelines (2018) of the ESC on the management of cardiovascular diseases during pregnancy
U. Seeland
J. Bauersachs
U. Kintscher
D. Hilfiker-Kleiner
J. W. Roos-Hesselink
V. Regitz-Zagrosek
Der Kardiologe, 2019, 13 (3): : 138 - 145
[33] ESC 2021 guidelines for the prevention of diseases cardiovascular disease in clinical practice
Visseren, Frank L. J.
Mach, Francois
Smulders, Yvo M.
Carballo, David
Koskinas, Konstantinos C.
Back, Maria
Benetos, Athanase
Biffi, Alessandro
Boavida, Jose-Manuel
Capodanno, Davide
Cosyns, Bernard
Crawford, Carolyn
Davos, Constantinos H.
Desormais, Ileana
Di Angelantonio, Emanuele
Franco, Oscar H.
Halvorsen, Sigrun
Hobbs, F. D. Richard
Hollander, Monika
Jankowska, Ewa A.
Michal, Matthias
Sacco, Simona
Sattar, Naveed
Tokgozoglu, Lale
Tonstad, Serena
Tsioufis, Konstantinos P.
van Dis, Ineke
van Gelder, Isabelle C.
Wanner, Christoph
Williams, Bryan
GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (06) : E3 - E115
[34] European Society of Cardiology Recommended Practice for the Treatment of Cardiovascular Disease in Patients with Diabetes 2023
Vrablik, Michal
Rosolova, Hana
Taborsky, Milos
COR ET VASA, 2024, 66 (02)
[35] Update Dyslipidaemias - Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Sinning, David
Landmesser, Ulf
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (11) : 816 - 820
[36] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
Prattichizzo, Francesco
La Sala, Lucia
Ryden, Lars
Marx, Nikolaus
Ferrini, Marc
Valensi, Paul
Ceriello, Antonio
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
[37] Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy. Most important facts
Seeland, U.
Bauersachs, J.
Roos-Hesselink, J.
Regitz-Zagrosek, V.
HERZ, 2018, 43 (08) : 710 - 718
[38] The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
Lee, Sun Hwa
Park, Jae-Hyeong
DIABETES & METABOLISM JOURNAL, 2023, 47 (04) : 470 - 483
[39] New Perspectives in Management of Cardiovascular Risk Among People With Diabetes
Gami, Abhishek
Blumenthal, Roger S.
Mcguire, Darren K.
Sarkar, Sudipa
Kohli, Payal
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12):
[40] Relevant aspects of the ESC guidelines for themanagement of cardiovascular diseases during pregnancy for obstetric anaesthesia (update 2018)
Brueck, S.
Seeland, U.
Kranke, E.
Kranke, P.
ANAESTHESIST, 2019, 68 (07): : 461 - 474

← 1 2 3 4 5 →